| Literature DB >> 31423056 |
M A Bujang1, P X Kuan1, F E Sapri1, W J Liu2, R Musa3.
Abstract
INTRODUCTION: Clinical parameters especially co-morbidities among end stage renal disease (ESRD) patients are associated with mortality. This study aims to determine the risk factors that are associated with mortality within three years among prevalent patients with ESRD.Entities:
Keywords: End stage renal disease; mortality; risk factors; screening tool; sensitivity and specificity
Year: 2019 PMID: 31423056 PMCID: PMC6668314 DOI: 10.4103/ijn.IJN_152_18
Source DB: PubMed Journal: Indian J Nephrol ISSN: 0971-4065
Univariate analysis for associated factors within demographic profile variables toward mortality within 3 years based on data from model development
| Variables | Category | Death | ||
|---|---|---|---|---|
| No, | Yes, | |||
| Age (years) | 18-39 | 85 (15.3) | 72 (19.7) | 0.178 |
| 40-64 | 333 (60.0) | 214 (58.6) | ||
| ≥65 | 137 (24.7) | 79 (21.6) | ||
| Gender | Male | 277 (49.5) | 189 (50.8) | 0.688 |
| Female | 283 (50.5) | 183 (49.2) | ||
| Ethnic | Malay | 275 (49.7) | 163 (44.3) | 0.111 |
| Chinese | 215 (38.9) | 163 (44.3) | ||
| Indian | 63 (11.4) | 40 (10.9) | ||
| Foreigner | 0 (0.0) | 2 (0.5) | ||
| Religion | Muslim | 276 (49.9) | 168 (46.0) | 0.252 |
| Buddhist | 185 (33.5) | 140 (38.4) | ||
| Hindu | 56 (10.1) | 33 (9.0) | ||
| Christian | 29 (5.2) | 23 (6.3) | ||
| Others | 7 (1.3) | 1 (0.3) | ||
| Marital status | Single | 133 (23.9) | 48 (12.9) | <0.001 |
| Married | 391 (70.2) | 276 (74.2) | ||
| Widow/widower | 27 (4.8) | 42 (11.3) | ||
| Divorced | 6 (1.1) | 6 (1.6) | ||
| Education | Nil | 31 (5.7) | 104 (28.3) | <0.001 |
| Primary | 135 (24.9) | 163 (44.4) | ||
| Secondary | 269 (49.6) | 48 (13.1) | ||
| Tertiary | 107 (19.7) | 52 (14.2) | ||
| Smoking history | Current | 22 (4.0) | 22 (5.9) | 0.170 |
| Former | 88 (15.8) | 69 (18.6) | ||
| Never | 446 (80.2) | 279 (75.4) | ||
| Alcohol history | Current | 2 (0.4) | 1 (0.3) | 0.793 |
| Former | 43 (7.7) | 33 (8.9) | ||
| Never | 511 (91.9) | 336 (90.8) | ||
Univariate analysis for associated factors within clinical variables toward mortality within 3 years based on data from model development
| Variables | Category | Death | ||
|---|---|---|---|---|
| No, | Yes, | |||
| Duration of dialysisa | 12.0 (20.0) | 10.7 (19.1) | 0.344 | |
| BMI categories | Underweight | 73 (13.1) | 39 (10.5) | 0.090 |
| Normal | 290 (52.1) | 172 (46.5) | ||
| Overweight | 138 (24.8) | 114 (30.8) | ||
| Obese | 56 (10.1) | 45 (12.2) | ||
| Mode dialysis | Hemodialysis | 401 (71.6) | 228 (61.3) | <0.001 |
| CAPD | 159 (28.4) | 144 (38.7) | ||
| Transplanted | No | 521 (93.0) | 364 (97.8) | 0.001 |
| Yes | 39 (7.0) | 8 (2.2) | ||
| Diabetes | No | 428 (76.4) | 185 (49.7) | <0.001 |
| Yes | 132 (23.6) | 187 (50.3) | ||
| Hypertension | No | 122 (21.8) | 47 (12.6) | <0.001 |
| Yes | 438 (78.2) | 325 (87.4) | ||
| CHD | No | 513 (91.6) | 283 (76.1) | <0.001 |
| Yes | 47 (8.4) | 89 (23.9) | ||
| Cerebrovascular | No | 546 (97.5) | 360 (96.8) | 0.510 |
| Yes | 14 (2.5) | 12 (3.2) | ||
| Leg-amputation | No | 552 (98.6) | 346 (93.0) | <0.001 |
| Yes | 8 (1.4) | 26 (7.0) | ||
| Cancer | No | 556 (99.3) | 365 (98.1) | 0.106 |
| Yes | 4 (0.7) | 7 (1.9) | ||
aReported in mean with standard deviation. BMI: Body mass index, CAPD: Continuous ambulatory peritoneal dialysis, CHD: Coronary heart disease
Summary of statistics derived from logistic regression model for Model 1 and Model 2 based on data from model development
| Predictor | Model 1a | Model 2b | ||||
|---|---|---|---|---|---|---|
| β | OR (95% CI) | β | OR (95%CI) | |||
| Education | ||||||
| Nil | 1.176 | 3.2 (1.8, 5.9) | <0.001 | |||
| Primary | 0.391 | 1.5 (0.9, 2.3) | 0.09 | |||
| Secondary | 0.257 | 1.3 (0.9, 2.0) | 0.23 | |||
| Tertiary | Reference group | |||||
| Mode of dialysis | ||||||
| Hemodialysis | Reference group | Reference group | ||||
| Peritoneal | 0.587 | 1.8 (1.3, 2.4) | <0.001 | 0.552 | 1.7 (1.3, 2.3) | <0.001 |
| Diabetes mellitus | ||||||
| No | Reference group | Reference group | ||||
| Yes | 1.001 | 2.7 (2.0, 3.7) | <0.001 | 1.086 | 3.0 (2.2, 4.0) | <0.001 |
| Chronic heart disease | ||||||
| No | Reference group | Reference group | ||||
| Yes | 0.998 | 2.7 (1.8, 4.1) | <0.001 | 1.027 | 2.8 (1.9, 4.2) | <0.001 |
| Leg amputation | ||||||
| No | Reference group | Reference group | ||||
| Yes | 0.929 | 2.5 (1.1, 6.0) | 0.03 | 1.043 | 2.8 (1.2, 6.6) | 0.016 |
| Constant | −1.471 | −1.174 | ||||
aMarital status, transplanted and hypertension were dropped from the stepwise analysis; AUC (95% CI) for Model 1: 0.711 (0.676, 0.745), bModel 2 only include clinical parameters; AUC (95% CI) for Model 2: 0.692 (0.656, 0.727). OR: Odd ratio, CI: Confidence interval, AUC: Area under the curve; β: Coefficient
The effect size of each significant clinical variables towards mortality within 3 years based on data from model development and the assigned score for Model 3 and Model 4
| Predictor | Crude OR (95% CI) | Score assigned | |
|---|---|---|---|
| Model 3a | Model 4b | ||
| Mode of dialysis | |||
| Hemodialysis | 0 | 0 | |
| Peritoneal | 1.6 (1.2, 2.1) | 1 | 1 |
| Diabetes mellitus | |||
| No | 0 | 0 | |
| Yes | 3.3 (2.5, 4.3) | 2 | 1 |
| Chronic heart disease | |||
| No | 0 | 0 | |
| Yes | 3.4 (2.3, 5.0) | 2 | 1 |
| Leg amputation | |||
| No | 0 | 0 | |
| Yes | 5.2 (2.3, 11.6) | 3 | 1 |
aAUC (95% CI) for Model 3: 0.697 (0.662, 0.731), bAUC (95% CI) for Model 4: 0.680 (0.645, 0.716). OR: Odd ratio, CI: Confidence interval, AUC: Area under the curve
Summary of the performance of Model 2 and Model 4 in predicting high risk of mortality within 3 years among prevalent end stage renal disease patients
| Statistics | Model development | Model validation |
|---|---|---|
| 1. Probability of event <0.8 versus ≥0.8a | ||
| Sensitivity | 9.95 (7.10, 13.45) | 8.83 (4.74, 13.37) |
| Specificity | 98.93 (97.68, 99.61) | 99.09 (96.75, 99.89) |
| Positive predicted value | 86.05 (72.44, 93.53) | 88.24 (63.48, 97.00) |
| Negative predicted value | 62.32 (61.50, 63.13) | 56.92 (55.79, 58.04) |
| 2. Probability of event <0.3 versus ≥0.3b | ||
| Sensitivity | 77.42 (72.83, 81.57) | 88.89 (83.36, 93.08) |
| Specificity | 49.11 (44.89, 53.33) | 25.45 (19.84, 31.75) |
| Positive predicted value | 50.26 (47.81, 52.71) | 49.38 (47.06, 51.70) |
| Negative predicted value | 76.60 (72.71, 80.09) | 73.68 (63.61, 81.77) |
| 3. Score 0-2 versus Score 3 and 4a | ||
| Sensitivity | 9.95 (7.10, 13.45) | 8.83 (4.74, 13.37) |
| Specificity | 98.93 (97.68, 99.61) | 99.09 (96.75, 99.89) |
| Positive predicted value | 86.05 (72.44, 93.53) | 88.24 (63.48, 97.00) |
| Negative predicted value | 62.32 (61.50, 63.13) | 56.92 (55.79, 58.04) |
| 4. Score 0 versus Score 1-4b | ||
| Sensitivity | 77.42 (72.83, 81.57) | 88.89 (83.36, 93.08) |
| Specificity | 49.11 (44.89, 53.33) | 25.45 (19.84, 31.75) |
| Positive predicted value | 50.26 (47.81, 52.71) | 49.38 (47.06, 51.70) |
| Negative predicted value | 76.60 (72.71, 80.09) | 73.68 (63.61, 81.77) |
aLow risk to high risk versus very high risk, bLow risk versus moderate to very high risk